Annual CFO
-$52.41 M
-$16.30 M-45.13%
December 31, 2023
Summary
- As of February 7, 2025, KYTX annual cash flow from operations is -$52.41 million, with the most recent change of -$16.30 million (-45.13%) on December 31, 2023.
- During the last 3 years, KYTX annual CFO has fallen by -$30.25 million (-136.56%).
- KYTX annual CFO is now -136.56% below its all-time high of -$22.16 million, reached on December 1, 2021.
Performance
KYTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$27.49 M
-$3.31 M-13.71%
September 30, 2024
Summary
- As of February 7, 2025, KYTX quarterly cash flow from operations is -$27.49 million, with the most recent change of -$3.31 million (-13.71%) on September 30, 2024.
- Over the past year, KYTX quarterly CFO has dropped by -$8.93 million (-48.08%).
- KYTX quarterly CFO is now -146.94% below its all-time high of -$11.13 million, reached on September 1, 2023.
Performance
KYTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$95.75 M
-$16.36 M-20.60%
September 30, 2024
Summary
- As of February 7, 2025, KYTX TTM cash flow from operations is -$95.75 million, with the most recent change of -$16.36 million (-20.60%) on September 30, 2024.
- Over the past year, KYTX TTM CFO has dropped by -$43.34 million (-82.70%).
- KYTX TTM CFO is now -735.68% below its all-time high of -$11.46 million, reached on March 1, 2023.
Performance
KYTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KYTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.1% | -48.1% | -82.7% |
| 3 y3 years | -136.6% | -48.1% | -82.7% |
| 5 y5 years | -136.6% | -48.1% | -82.7% |
KYTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -136.6% | at low | -146.9% | at low | -735.7% | at low |
| 5 y | 5-year | -136.6% | at low | -146.9% | at low | -735.7% | at low |
| alltime | all time | -136.6% | at low | -146.9% | at low | -735.7% | at low |
Kyverna Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.49 M(+13.7%) | -$95.75 M(+20.6%) |
| Jun 2024 | - | -$24.18 M(-5.3%) | -$79.39 M(+19.4%) |
| Mar 2024 | - | -$25.52 M(+37.5%) | -$66.48 M(+26.8%) |
| Dec 2023 | -$52.41 M | -$18.56 M(+66.8%) | -$52.41 M(+54.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$11.13 M(-1.1%) | -$33.85 M(+49.0%) |
| Jun 2023 | - | -$11.26 M(-1.8%) | -$22.71 M(+98.2%) |
| Mar 2023 | - | -$11.46 M | -$11.46 M |
| Dec 2022 | -$36.11 M(+63.0%) | - | - |
| Dec 2021 | -$22.16 M | - | - |
FAQ
- What is Kyverna Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Kyverna Therapeutics?
- What is Kyverna Therapeutics annual CFO year-on-year change?
- What is Kyverna Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kyverna Therapeutics?
- What is Kyverna Therapeutics quarterly CFO year-on-year change?
- What is Kyverna Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Kyverna Therapeutics?
- What is Kyverna Therapeutics TTM CFO year-on-year change?
What is Kyverna Therapeutics annual cash flow from operations?
The current annual CFO of KYTX is -$52.41 M
What is the all time high annual CFO for Kyverna Therapeutics?
Kyverna Therapeutics all-time high annual cash flow from operations is -$22.16 M
What is Kyverna Therapeutics annual CFO year-on-year change?
Over the past year, KYTX annual cash flow from operations has changed by -$16.30 M (-45.13%)
What is Kyverna Therapeutics quarterly cash flow from operations?
The current quarterly CFO of KYTX is -$27.49 M
What is the all time high quarterly CFO for Kyverna Therapeutics?
Kyverna Therapeutics all-time high quarterly cash flow from operations is -$11.13 M
What is Kyverna Therapeutics quarterly CFO year-on-year change?
Over the past year, KYTX quarterly cash flow from operations has changed by -$8.93 M (-48.08%)
What is Kyverna Therapeutics TTM cash flow from operations?
The current TTM CFO of KYTX is -$95.75 M
What is the all time high TTM CFO for Kyverna Therapeutics?
Kyverna Therapeutics all-time high TTM cash flow from operations is -$11.46 M
What is Kyverna Therapeutics TTM CFO year-on-year change?
Over the past year, KYTX TTM cash flow from operations has changed by -$43.34 M (-82.70%)